scholarly journals ES Cell Extract-Induced Expression of Pluripotent Factors in Somatic Cells

2009 ◽  
Vol 292 (8) ◽  
pp. 1229-1234 ◽  
Author(s):  
Yan-Ning Xu ◽  
Na Guan ◽  
Zhen-Dong Wang ◽  
Zhi-Yan Shan ◽  
Jing-Ling Shen ◽  
...  
Blood ◽  
2010 ◽  
Vol 116 (3) ◽  
pp. 386-395 ◽  
Author(s):  
Hyun-Jai Cho ◽  
Choon-Soo Lee ◽  
Yoo-Wook Kwon ◽  
Jae Seung Paek ◽  
Sun-Hee Lee ◽  
...  

Abstract The concept of reprogramming of somatic cells has opened a new era in regenerative medicine. Transduction of defined factors has successfully achieved pluripotency. However, during the generation process of induced pluripotent stem (iPS) cells, genetic manipulation of certain factors may cause tumorigenicity, which limits further application. We report that that a single transfer of embryonic stem (ES) cell–derived proteins into primarily cultured adult mouse fibroblasts, rather than repeated transfer or prolonged exposure to materials, can achieve full reprogramming up to the pluripotent state without the forced expression of ectopic transgenes. During the process, gene expression and epigenetic status were converted from somatic to ES-equivalent status. We verified that protein-based reprogramming was neither by the contamination of protein donor ES cell nor by DNA/RNA from donor ES cell. Protein-iPS cells were biologically and functionally very similar to ES cells and differentiated into 3 germ layers in vitro. Furthermore, protein-iPS cells possessed in vivo differentiation (well-differentiated teratoma formation) and development (chimeric mice generation and a tetraploid blastocyst complementation) potentials. Our results provide an alternative and safe strategy for the reprogramming of somatic cells that can be used to facilitate pluripotent stem cell–based cell therapy.


2015 ◽  
Vol 27 (1) ◽  
pp. 114
Author(s):  
D. Iuso ◽  
M. Czernik ◽  
P. Toschi ◽  
F. Zacchini ◽  
H. Shiota ◽  
...  

The post-meiotic phase of spermatogenesis is characterised by a radical reorganization of the chromatin, leading to its nucleosomal to toroid transition. The replacement of histones with protamine is a gradual process regulated to the hierarchical translation of repressed mRNAs leading to the following events: incorporation of testis-specific histone variants and general histone hyperacetylation, bromodomain proteins, transition proteins, concluded by protamine incorporation on DNA. In this work, we tested whether the induced expression of human protamine 1 (PR1) in sheep somatic cells could induce a protamine/toroid conformation of interphase nuclei. Sheep adult fibroblasts (SAF) were cultured in DMEM with 10% fetal bovine serum from second to eighth passage. Then, SAF at 80% confluence were transfected with 3 μg of pPR1-red fluorescent protein (RFP) and pRFP (CTR) with lipofectamine. At 4 h post-transfection, cells were treated with 5 nM trichostatin A (TSA; histone deacethylase inhibitor) for an additional 16 h. Transfected cells (visualised through the RFP tag) were analysed for nuclear morphology (transmission electron microscopy), PR1-RFP expression (confocal microscope, RT-PCR, Western blot), cytofluorimeter, DNA damage (comet assay, pH2A.X immune-detection), and chromatin immune-precipitation assays (ChIP). Moreover, to visualise the histone/protamine exchange, we transfected with PR1 mouse GFP-H2B fibroblasts. Protaminized cells were used as donors for nuclear transfer (NT) and TH2B (testis/oocyte-specific histone normally present in male pronucleus, a marker of reprogramming) was detected in pronuclear stage of NT zygotes. The χ2 test was used for statistical analyses. We demonstrated that PR1 translocates into the nuclei and gradually compacts them into elongating spermatid-like structures in 48 h; TSA treatment facilitates the process [TSA 83.3% (50/60); without TSA 55.2%; 58/105; P < 0.0003]. A complete histone-to-protamine exchange was also visualised in GFP-H2B nuclei (mouse fibroblasts) 40h after PR1 transfection. Cytofluorimetric analysis demonstrated that protamine incorporation occurs in any cell cycle stage and without DNA breaks. Next, protamine-protamine binding was excluded by ChIP analysis, which confirmed protamine-DNA binding. Finally, protaminized nuclei transplanted into enucleated oocytes incorporated maternal histone TH2B (3/8), whereas no signal was detected in control cells (0/9), suggesting that protaminized nuclei are better remodelled. We conclude that the induced expression of PR1 forces the somatic chromatin to acquire a structure overlapping elongated spermatid/spermatozoa, a conformation that perfectly matches the nuclear reprogramming machinery of the oocyte. Further work will determine whether protaminized cells are better reprogrammed upon nuclear transfer.


2008 ◽  
Vol 314 (14) ◽  
pp. 2634-2642 ◽  
Author(s):  
Thierry Bru ◽  
Catriona Clarke ◽  
Michael J. McGrew ◽  
Helen M. Sang ◽  
Ian Wilmut ◽  
...  

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 311-311
Author(s):  
Charlie R. Mantel ◽  
Ying Guo ◽  
Myung-Kwan Han ◽  
Sara Roharbaugh ◽  
Barbara Graham-Evans ◽  
...  

Abstract Maintenance of a euploid ES cell genome during ex-vivo expansion and differentiation to hematopoietic cells is essential for their safe use in therapeutic intervention and regenerative medicine. It is estimated that about half of all spontaneous mutations that occur in cultured murine ES cells are attributable to chromosomal non-disjunction and chromosome loss. This type of mutation is essentially undetectable in somatic cell cultures of comparable culture age. The mechanisms responsible for this difference between ES and somatic cells are unknown, but are likely related to the absence of a rigorous G1 cell cycle checkpoint and other peculiarities in ES cell cycle regulation compared to somatic cells. The fate of aneuploid ES cells during differentiation has not been systematically studied. Here, we report a remarkable tolerance for aneuploidy/polyploidy in murine ES cells in-vitro when challenged by mitotic stress that is induced by failed cell division followed by mitotic slippage resulting in stable, cycling, tetraploid/polyploid ES cell lines (oscillating between 4N and 8N). We present evidence supporting the idea that canonical apoptosis is uncoupled from mitotic checkpoints in undifferentiated ES cells in contrast to somatic cells and embryoid body (EB) cells. We also present evidence suggesting similar behavior occurs in human ES cell cultures. Uncoupling was associated with low levels of the pro-apoptotic form of phospho-BAD (p-ser128) combined with high expression of anti-apoptotic Survivin in ES compared to EB cells. This suggests uncoupling from mitotic checkpoints may be related to a heightened apoptotic threshold in ES cells compared to EB/somatic cells. Interestingly, culture of ES cells under hypoxic conditions also generated polyploid cells. The polyploid ES cells did not appear to be trophoblastic cells because they continue to express SSEA-1 and other markers of pluripotency. However, we demonstrate that (re-)coupling occurs very early in the differentiation process because only diploid ES cells contribute to EB formation while tetraploid cells do not when EBs are generated from tetraploid/diploid-mosaic cultures. This is, to our knowledge, the first evidence that there may be a potent in-vitro barrier to cells with numerical chromosomal aberrations from contributing to differentiated cells to be used in therapeutic settings. Finally, using a conditional oct-4 knock-down ES cell line, we demonstrate that the self-renewal regulating transcription factor, oct-4, is essential for maintaining the aneuploidy/polyploidy tolerant state. We conclude that aneuploidy/polyploidy-tolerance in pluripotent ES cells in-vitro is an expected occurrence when viewed within the context of ex-vivo ES cell culture where apoptotic culling of cells with chromosomal aberrations, which normally occurs in vertebrate embryos during the peri-implantation period in-vivo, has been artificially interrupted by ES cell derivation. This behavior likely contributes significantly to spontaneous aneuploidization in murine and human ES cell cultures. These data not only lend insight into mechanisms of aneuploidy in ES cell cultures but may also have implications for mechanisms of aneuploidy during tumorigenesis.


2006 ◽  
Vol 26 (24) ◽  
pp. 9471-9483 ◽  
Author(s):  
Peili Gu ◽  
Damien Le Menuet ◽  
Arthur C.-K. Chung ◽  
Austin J. Cooney

ABSTRACT The pluripotent factor Oct4 is a key transcription factor that maintains embryonic stem (ES) cell self-renewal and is down-regulated upon the differentiation of ES cells and silenced in somatic cells. A combination of cis elements, transcription factors, and epigenetic modifications, such as DNA methylation, are involved in the regulation of Oct4 gene expression. Here we show that the orphan nuclear receptor GCNF initiates Oct4 repression and DNA methylation by the differential recruitment of MBD (methylated CpG binding domain) factors to the promoter. Compared with wild-type ES cells and gastrulating embryos, Oct4 repression is lost and its proximal promoter is significantly hypomethylated in RA-differentiated GCNF−/− ES cells. The Oct4 gene is reexpressed in some somatic cells of GCNF−/− embryos, showing that it has not been properly silenced coincident with reduced DNA methylation of its promoter. Efforts to characterize mediators of GCNF's repressive function and DNA methylation of the Oct4 promoter identified methyl-DNA binding proteins, MBD3 and MBD2, as GCNF-interacting factors. In P19 and ES cells, upon differentiation, endogenous GCNF binds to the Oct4 proximal promoter and differentially recruits MBD3 and MBD2. In differentiated GCNF−/− ES cells, recruitment of MBD3 and MBD2 to the Oct4 promoter is lost, and repression of Oct4 expression and DNA methylation fails to occur. RNA interference-mediated knockdown of MBD3 and/or MBD2 expression results in reduced Oct4 repression in differentiated P19 and ES cells. Repression of Oct4 expression and recruitment of MBD3 are maintained in de novo DNA methylation-deficient ES cells (Dnmt3A/3B-null cells), while MBD2 recruitment is lost. Thus, recruitment of MBD3 and MBD2 by GCNF links two events, gene-specific repression and DNA methylation, which occur differentially at the Oct4 promoter. GCNF initiates the repression and epigenetic modification of Oct4 gene during ES cell differentiation.


2001 ◽  
Vol 13 (1) ◽  
pp. 23 ◽  
Author(s):  
Martin F. Pera

The recent development of embryonic stem (ES) cells from human blastocysts has the potential to revolutionize many of our approaches to human biology and medicine. Continued objection to the use of human ES cells on ethical grounds may inhibit progress or defer this opportunity indefinitely. It is essential that the ethical discussion proceed on a sound scientific basis. The ethical controversy surrounding human ES cells concerns their origin from human blastocysts and the perception of their developmental potential. It is likely that the worldwide requirement for human ES cells will be met by the development of a small number of cell lines, as has been the case in the mouse; current rates of success for human ES cell establishment suggest that only a modest number of embryos will be required to achieve this goal. It is in the public interest that human ES cell lines be derived under circumstances that will enable their widespread distribution with minimum encumbrances to academic researchers throughout the world. In considering the developmental potential of ES cells, an important distinction exists between pluripotentiality, or the ability to develop into a wide range of somatic and extraembryonic tissues, and totipotentiality, the ability of a cell or collection of cells to give rise to a new individual given adequate maternal support. There is no evidence that ES cells from any species can give rise to a new individual except when combined with cells which are the immediate progeny of a zygote. These developmental limitations of ES cells appear to relate to their inability to undergo axis formation and to generate the body plan. Alternatives to blastocyst-derived ES cells include embryonic germ cells, adult tissue stem cells, transdetermination of committed somatic cells, and therapeutic cloning. These research areas are complimentary and synergistic to ES cell research and it is premature and counterproductive to suggest that one avenue should be pursued in preference to another. The combination of cloning and ES cell technology has the potential to address many important issues in transplantation medicine and research, but a better understanding of the reprogramming of somatic cells is required before we can regard ES cells derived from normal nd nuclear transfer blastocysts as equivalent.


Author(s):  
Carolyn A. Larabell ◽  
David G. Capco ◽  
G. Ian Gallicano ◽  
Robert W. McGaughey ◽  
Karsten Dierksen ◽  
...  

Mammalian eggs and embryos contain an elaborate cytoskeletal network of “sheets” which are distributed throughout the entire cell cytoplasm. Cytoskeletal sheets are long, planar structures unlike the cytoskeletal networks typical of somatic cells (actin filaments, microtubules, and intermediate filaments), which are filamentous. These sheets are not found in mammalian somatic cells nor are they found in nonmammalian eggs or embryos. Evidence that they are, indeed, cytoskeletal in nature is derived from studies demonstrating that 1) the sheets are retained in the detergent-resistant cytoskeleton fraction; 2) there are no associated membranes (determined by freeze-fracture); and 3) the sheets dissociate into filaments at the blastocyst stage of embryogenesis. Embedment-free sections of hamster eggs viewed at 60 kV show sheets running across the egg cytoplasm (Fig. 1). Although this approach provides excellent global views of the sheets and their reorganization during development, the mechanism of image formation for embedment-free sections does not permit evaluation of the sheets at high resolution.


Sign in / Sign up

Export Citation Format

Share Document